 |
PDBsum entry 4mo2
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Pore analysis for: 4mo2 calculated with MOLE 2.0
|
PDB id
|
|
|
|
4mo2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Pores calculated on whole structure |
 |
Pores calculated excluding ligands
|
|
|
 |
 |
 |
 |
 |
|
 |
|
|
|
 |
 |
|
 |
|
|
|
 |
3 pores,
coloured by radius |
 |
6 pores,
coloured by radius
|
6 pores,
coloured as in list below
|
|
|
 |
 |
 |
Pores are connected internal spaces going through the structure. Only pores longer than 25 Å are shown. |
|
|
 |
|
|
|
 |
Free R
|
 |
|
|
|
|
 |
Length
|
 |
|
|
|
|
 |
HPathy
|
 |
|
|
|
|
 |
HPhob
|
 |
|
|
|
|
 |
Polar
|
 |
|
|
|
|
 |
Rel Mut
|
 |
|
|
|
|
 |
Residue..type
|
 |
|
|
|
|
 |
Ligands
|
 |
|
|
|
|
|
 |
Radius |
 |
1 |
 |
1.32 |
4.80 |
36.8 |
-1.72 |
-0.13 |
13.6 |
71 |
 |
5 |
4 |
1 |
1 |
4 |
1 |
0 |
 |
|
 |
 |
2 |
 |
1.32 |
5.48 |
45.4 |
-1.25 |
0.00 |
10.7 |
72 |
2 |
3 |
3 |
3 |
5 |
2 |
0 |
|
 |
3 |
 |
1.18 |
5.47 |
55.3 |
-1.01 |
-0.09 |
12.3 |
71 |
4 |
3 |
3 |
8 |
6 |
1 |
2 |
FDA 402 B
|
 |
4 |
 |
2.20 |
2.20 |
58.6 |
-1.45 |
-0.05 |
17.6 |
75 |
7 |
4 |
2 |
6 |
6 |
0 |
2 |
FAD 405 A
|
 |
5 |
 |
2.23 |
2.37 |
58.9 |
-1.34 |
-0.11 |
16.8 |
73 |
7 |
4 |
2 |
7 |
7 |
0 |
2 |
FDA 402 B
|
 |
6 |
 |
2.20 |
2.39 |
100.1 |
-1.80 |
-0.21 |
23.7 |
88 |
10 |
4 |
8 |
2 |
2 |
1 |
0 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Residue-type_colouring |
 |
|
 |
|
Positive
|
Negative
|
Neutral
|
Aliphatic
|
Aromatic
|
Pro & Gly
|
Cysteine
|
|
H,K,R
|
D,E
|
S,T,N,Q
|
A,V,L,I,M
|
F,Y,W
|
P,G
|
C
|
|
|
 |